FI109700B - Menetelmä uusien terapeuttisesti käyttökelpoisten syklisten fruktopyranoosisulfiittien ja -sulfaattien valmistamiseksi - Google Patents
Menetelmä uusien terapeuttisesti käyttökelpoisten syklisten fruktopyranoosisulfiittien ja -sulfaattien valmistamiseksi Download PDFInfo
- Publication number
- FI109700B FI109700B FI931888A FI931888A FI109700B FI 109700 B FI109700 B FI 109700B FI 931888 A FI931888 A FI 931888A FI 931888 A FI931888 A FI 931888A FI 109700 B FI109700 B FI 109700B
- Authority
- FI
- Finland
- Prior art keywords
- formula
- methylethylidene
- sulfonyl
- fructopyranose
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Detergent Compositions (AREA)
- Treating Waste Gases (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Optical Radar Systems And Details Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/874,875 US5242942A (en) | 1992-04-28 | 1992-04-28 | Anticonvulsant fructopyranose cyclic sulfites and sulfates |
US87487592 | 1992-04-28 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI931888A0 FI931888A0 (fi) | 1993-04-27 |
FI931888A FI931888A (fi) | 1993-10-29 |
FI109700B true FI109700B (fi) | 2002-09-30 |
Family
ID=25364769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI931888A FI109700B (fi) | 1992-04-28 | 1993-04-27 | Menetelmä uusien terapeuttisesti käyttökelpoisten syklisten fruktopyranoosisulfiittien ja -sulfaattien valmistamiseksi |
Country Status (14)
Country | Link |
---|---|
US (1) | US5242942A (no) |
EP (1) | EP0568306B1 (no) |
JP (1) | JP3356324B2 (no) |
AT (1) | ATE145914T1 (no) |
AU (1) | AU658287B2 (no) |
CA (1) | CA2094859C (no) |
DE (1) | DE69306298T2 (no) |
DK (1) | DK0568306T3 (no) |
ES (1) | ES2097448T3 (no) |
FI (1) | FI109700B (no) |
MX (1) | MX9302503A (no) |
NO (1) | NO180011C (no) |
NZ (1) | NZ247468A (no) |
SG (1) | SG64296A1 (no) |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5258402A (en) | 1992-06-11 | 1993-11-02 | Mcneil-Ppc, Inc. | Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates |
US5384327A (en) * | 1992-12-22 | 1995-01-24 | Mcneilab, Inc. | Anticonvulsant sorbopyranose sulfamates |
DE69434652T2 (de) * | 1993-12-23 | 2007-03-01 | Ortho-Mcneil Pharmaceutical, Inc. | Antikonvulsive pseudofructopyranose sulfamate |
US5998380A (en) * | 1995-10-13 | 1999-12-07 | New England Medical Center Hospitals, Inc. | Treatment of migraine |
DK0915697T3 (da) * | 1996-06-28 | 2003-01-27 | Ortho Mcneil Pharm Inc | Antikonvulsive sulfamatderivater, som er anvendelige ved behandling af fedme |
CZ20013061A3 (cs) * | 1999-02-24 | 2002-06-12 | University Of Cincinnati | Pouľití sulfamátových derivátů pro léčbu poruch kontroly impulsů |
CA2369091C (en) * | 1999-04-08 | 2005-01-11 | Ortho-Mcneil Pharmaceutical, Inc. | Anticonvulsant derivatives useful in lowering blood pressure |
JP2003521471A (ja) * | 1999-04-08 | 2003-07-15 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 慢性神経変性疾患を処置することに有用な抗痙攣薬誘導体 |
US7056890B2 (en) | 1999-06-14 | 2006-06-06 | Vivus, Inc. | Combination therapy for effecting weight loss and treating obesity |
US20080255093A1 (en) * | 1999-06-14 | 2008-10-16 | Tam Peter Y | Compositions and methods for treating obesity and related disorders |
US7674776B2 (en) * | 1999-06-14 | 2010-03-09 | Vivus, Inc. | Combination therapy for effecting weight loss and treating obesity |
US20080103179A1 (en) * | 2006-10-27 | 2008-05-01 | Tam Peter Y | Combination Therapy |
US7659256B2 (en) * | 1999-06-14 | 2010-02-09 | Vivus, Inc. | Combination therapy for effecting weight loss and treating obesity |
US7553818B2 (en) * | 1999-06-14 | 2009-06-30 | Vivus, Inc. | Combination therapy for effecting weight loss and treating obesity |
ATE309261T1 (de) | 1999-07-26 | 2005-11-15 | Ortho Mcneil Pharm Inc | Trizyklisch-monosaccharid-derivative verwendbar bei der behandlung von akuten ischamisch- induzierten neurodegenerationen |
RU2268720C2 (ru) * | 2000-07-07 | 2006-01-27 | Орто-Макнейл Фармасьютикал, Инк. | Противосудорожные производные, используемые для профилактики развития сахарного диабета и синдрома х |
JP2004505043A (ja) | 2000-08-02 | 2004-02-19 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | うつ病の治療で用いるに有用な抗痙攣性誘導体 |
DK1333887T3 (da) * | 2000-10-30 | 2006-11-13 | Ortho Mcneil Pharm Inc | Kombinationsbehandling omfattende antidiabetiske og antikonvulsive midler |
ES2284858T3 (es) | 2001-02-02 | 2007-11-16 | Ortho-Mcneil Pharmaceutical, Inc. | Tratamiento de disfuncion neurologica que comprende sulfamatos de fructopiranosa y eritropoyetina. |
UA78211C2 (en) * | 2001-07-09 | 2007-03-15 | Ortho Mcneil Pharm Inc | Salts of fructopyranose derivatives as anticonvulsant |
US7041650B2 (en) * | 2001-07-09 | 2006-05-09 | Ortho-Mcneil Pharmaceutical, Inc. | Anticonvulsant derivative salts |
MXPA04004380A (es) * | 2001-11-06 | 2005-06-08 | Johnson & Johnson | Tratamiento y prevencion de parestesia que comprende co-terapia con derivados anticonvulsivos y potasio. |
US20100311701A1 (en) * | 2002-02-15 | 2010-12-09 | Transform Pharmaceuticals, Inc | Pharmaceutical Co-Crystal Compositions |
US6559293B1 (en) | 2002-02-15 | 2003-05-06 | Transform Pharmaceuticals, Inc. | Topiramate sodium trihydrate |
US7927613B2 (en) | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
US20090088443A1 (en) * | 2002-02-15 | 2009-04-02 | Julius Remenar | Novel crystalline forms of conazoles and methods of making and using the same |
US7790905B2 (en) * | 2002-02-15 | 2010-09-07 | Mcneil-Ppc, Inc. | Pharmaceutical propylene glycol solvate compositions |
US20030225002A1 (en) * | 2002-02-26 | 2003-12-04 | Livingstone Ian R. | Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents |
CA2477923C (en) | 2002-03-01 | 2021-02-23 | University Of South Florida | Multiple-component solid phases containing at least one active pharmaceutical ingredient |
US7060725B2 (en) * | 2002-05-13 | 2006-06-13 | Janssen Pharmaceutica N.V. | Substituted sulfamate anticonvulsant derivatives |
US20070059356A1 (en) * | 2002-05-31 | 2007-03-15 | Almarsson Oern | Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
CN100360117C (zh) * | 2002-06-21 | 2008-01-09 | 转化医药公司 | 具有提高的溶出度的药物组合物 |
US7196209B2 (en) * | 2002-10-31 | 2007-03-27 | Ortho-Mcneil Pharmaceutical, Inc. | Continuous process for the preparation of fructopyranose sulfamate derivatives |
US8183290B2 (en) | 2002-12-30 | 2012-05-22 | Mcneil-Ppc, Inc. | Pharmaceutically acceptable propylene glycol solvate of naproxen |
MY147767A (en) * | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
TW200612905A (en) * | 2004-06-16 | 2006-05-01 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
US20060047001A1 (en) * | 2004-08-24 | 2006-03-02 | Parker Michael H | Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents |
CN101754947A (zh) * | 2005-05-20 | 2010-06-23 | 詹森药业有限公司 | 磺酰胺衍生物的制备方法 |
US8378117B2 (en) * | 2005-09-23 | 2013-02-19 | Janssen Pharmaceutica N.V. | Hexahydro-cycloheptapyrazole cannabinoid modulators |
DE602006012514D1 (de) * | 2005-09-23 | 2010-04-08 | Janssen Pharmaceutica Nv | Hexahydro-cyclooctyl-pyrazol-cannabinoid-modulatoren |
CA2623803A1 (en) | 2005-09-23 | 2007-03-29 | Janssen Pharmaceutica N.V. | Tetrahydro-cyclopentyl pyrazole cannabinoid modulators |
US8378096B2 (en) * | 2005-09-23 | 2013-02-19 | Janssen Pharmaceutica N.V. | Hexahydro-cycloheptapyrazole cannabinoid modulators |
US7825151B2 (en) * | 2005-09-23 | 2010-11-02 | Janssen Pharmaceutica Nv | Hexahydro-cyclooctyl pyrazole cannabinoid modulators |
ATE534387T1 (de) * | 2005-09-23 | 2011-12-15 | Janssen Pharmaceutica Nv | Hexahydro-cycloheptapyrazol-cannabinoid- modulatoren |
US20070117858A1 (en) * | 2005-11-23 | 2007-05-24 | Mingde Xia | Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators |
US20070155827A1 (en) * | 2005-12-19 | 2007-07-05 | Smith-Swintosky Virginia L | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression |
US8937096B2 (en) | 2005-12-19 | 2015-01-20 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
US8497298B2 (en) * | 2005-12-19 | 2013-07-30 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
US8716231B2 (en) | 2005-12-19 | 2014-05-06 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
US20070155823A1 (en) * | 2005-12-19 | 2007-07-05 | Smith-Swintosky Virginia L | Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents |
US20070155824A1 (en) * | 2005-12-19 | 2007-07-05 | Smith-Swintosky Virginia L | Use of benzo-fused heterocycle sulfamide derivatives for disease modification / epileptogenesis |
US8492431B2 (en) * | 2005-12-19 | 2013-07-23 | Janssen Pharmaceutica, N.V. | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity |
US8691867B2 (en) * | 2005-12-19 | 2014-04-08 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
US7526911B2 (en) * | 2006-02-03 | 2009-05-05 | Rolls-Royce Corporation | Gas turbine engine fuel system with fuel metering valve |
US7795294B2 (en) * | 2006-02-14 | 2010-09-14 | Janssen Pharmaceutica N.V. | Tetrahydro-2H-indazole pyrazole cannabinoid modulators |
US20070191474A1 (en) * | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine |
US20070191453A1 (en) * | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of benzo-heteroaryl sulfamide derivatives for the treatment of substance abuse and addiction |
US20070191450A1 (en) * | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Mania and Bipolar Disorder |
US20070191461A1 (en) * | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of benzo-heteroaryl sulfamide derivatives for the treatment of migraine |
US20070191459A1 (en) * | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of Benzo-Heteroaryl Sulfamide Derivatives for Lowering Lipids and Lowering Blood Glucose Levels |
US20070191460A1 (en) * | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Disease Modification / Epileptogenesis |
US20070191451A1 (en) * | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of benzo-heteroaryl sulfamide derivatives as neuroprotective agents |
US20070191449A1 (en) * | 2006-02-15 | 2007-08-16 | Smith-Swintosky Virginia L | Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Depression |
US8012957B2 (en) * | 2006-03-27 | 2011-09-06 | Janssen Pharmaceutica Nv | Tetrahydro-1H-1,2,6-triaza-azulene cannabinoid modulators |
US20070254911A1 (en) * | 2006-03-27 | 2007-11-01 | Mingde Xia | Tetrahydro-Pyrazolo[3,4-c]Pyridine Cannabinoid Modulators |
EA200870556A1 (ru) * | 2006-05-19 | 2009-06-30 | Янссен Фармацевтика Н.В. | Комбинированная терапия в лечении эпилепсии и родственных расстройств |
US7943653B2 (en) * | 2007-08-13 | 2011-05-17 | Janssen Pharmaceutica N.V. | Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators |
US20090247617A1 (en) * | 2008-03-26 | 2009-10-01 | Abdel-Magid Ahmed F | Process for the preparation of benzo-fused heteroaryl sulfamates |
US8580298B2 (en) * | 2008-06-09 | 2013-11-12 | Vivus, Inc. | Low dose topiramate/phentermine composition and methods of use thereof |
US20090304789A1 (en) | 2008-06-09 | 2009-12-10 | Thomas Najarian | Novel topiramate compositions and an escalating dosing strategy for treating obesity and related disorders |
WO2010008776A2 (en) | 2008-06-23 | 2010-01-21 | Janssen Pharmaceutica Nv | Disposable patch and reusable sensor assembly for use in medical device localization and mapping systems |
US8815939B2 (en) * | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
NL2021840B1 (en) | 2018-10-19 | 2020-05-13 | Univ Leiden | Pharmacological Chaperones For Enzyme Treatment Therapy |
WO2020046132A1 (en) | 2018-08-31 | 2020-03-05 | Leiden University | Pharmacological chaperones for enzyme treatment therapy |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2792398A (en) * | 1954-12-03 | 1957-05-14 | Miles Lab | Piperazine derivatives |
PH12617A (en) * | 1973-04-13 | 1979-07-05 | Thomae Gmbh Dr K | Aminobenzyl-amides and salts thereof |
US3997585A (en) * | 1974-12-30 | 1976-12-14 | Ortho Pharmaceutical Corporation | Aliphatic sulfamates |
US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
US4591601A (en) * | 1985-04-12 | 1986-05-27 | Mcneilab, Inc. | Anticonvulsant dioxolane methane sulfamates |
US4792569A (en) * | 1987-08-27 | 1988-12-20 | Mcneilab, Inc. | Anticonvulsant phenethyl sulfamates |
-
1992
- 1992-04-28 US US07/874,875 patent/US5242942A/en not_active Expired - Lifetime
-
1993
- 1993-04-21 NZ NZ247468A patent/NZ247468A/en not_active IP Right Cessation
- 1993-04-21 AU AU37073/93A patent/AU658287B2/en not_active Expired
- 1993-04-26 CA CA002094859A patent/CA2094859C/en not_active Expired - Lifetime
- 1993-04-27 DK DK93303263.3T patent/DK0568306T3/da active
- 1993-04-27 NO NO931529A patent/NO180011C/no not_active IP Right Cessation
- 1993-04-27 JP JP12361193A patent/JP3356324B2/ja not_active Expired - Lifetime
- 1993-04-27 ES ES93303263T patent/ES2097448T3/es not_active Expired - Lifetime
- 1993-04-27 FI FI931888A patent/FI109700B/fi not_active IP Right Cessation
- 1993-04-27 EP EP93303263A patent/EP0568306B1/en not_active Expired - Lifetime
- 1993-04-27 AT AT93303263T patent/ATE145914T1/de active
- 1993-04-27 DE DE69306298T patent/DE69306298T2/de not_active Expired - Lifetime
- 1993-04-27 SG SG1996001446A patent/SG64296A1/en unknown
- 1993-04-28 MX MX9302503A patent/MX9302503A/es unknown
Also Published As
Publication number | Publication date |
---|---|
MX9302503A (es) | 1994-05-31 |
NO180011B (no) | 1996-10-21 |
NO180011C (no) | 1997-01-29 |
SG64296A1 (en) | 1999-04-27 |
CA2094859C (en) | 2005-08-16 |
NO931529D0 (no) | 1993-04-27 |
ATE145914T1 (de) | 1996-12-15 |
DK0568306T3 (da) | 1996-12-23 |
EP0568306B1 (en) | 1996-12-04 |
FI931888A0 (fi) | 1993-04-27 |
EP0568306A1 (en) | 1993-11-03 |
AU658287B2 (en) | 1995-04-06 |
ES2097448T3 (es) | 1997-04-01 |
AU3707393A (en) | 1993-11-04 |
JP3356324B2 (ja) | 2002-12-16 |
NZ247468A (en) | 1994-09-27 |
US5242942A (en) | 1993-09-07 |
CA2094859A1 (en) | 1993-10-29 |
NO931529L (no) | 1993-10-29 |
DE69306298D1 (de) | 1997-01-16 |
JPH07291988A (ja) | 1995-11-07 |
DE69306298T2 (de) | 1997-05-22 |
FI931888A (fi) | 1993-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI109700B (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten syklisten fruktopyranoosisulfiittien ja -sulfaattien valmistamiseksi | |
KR100241860B1 (ko) | 약제학적으로 유용한 항경련제 설파메이트의 이미데이트 유도체 | |
FI79095C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara sulfamatfoereningar. | |
US5384327A (en) | Anticonvulsant sorbopyranose sulfamates | |
US20060058373A1 (en) | Novel substituted sulfamate anticonvulsant derivatives | |
Ogawa et al. | Synthetic studies on nephritogenic glycosides. Synthesis of N-(β-l-Aspartyl)-α-d-glucopyranosylamine | |
RU2139875C1 (ru) | Сульфаматы псевдофруктопиранозы и фармацевтическая композиция на их основе | |
CA1252109A (en) | Anticonvulsant dioxolane methane sulfamates | |
PT95861A (pt) | Processo para a preparacao de derivados de desoxi-fluoro-nucleosidos | |
Lin et al. | Syntheses and biological evaluations of 3'-deoxy-3'-C-branched-chain-substituted nucleosides | |
Kozikowski et al. | An efficacious synthesis of aryl and heteroaryl C-glycosides | |
Yoshimura et al. | Branched-chain sugars. XXXV. The synthesis of L-rubranitrose (2, 3, 6-trideoxy-3-C-methyl-4-O-methyl-3-nitro-L-xylo-hexopyranose). | |
Borsuk et al. | Six‐membered cyclic sulfites derived from glucofuranose and 1, 2, 4‐butanetriol | |
Lorin et al. | Novel approach to the synthesis of sugar sulfones via trans-sulfonylation of a unique heteroaryl precursor | |
EP1204669B1 (en) | Tricyclic monosaccharide derivatives useful in treating acute ischemia-induced neurodegeneration | |
OGAWA et al. | Synthetic studies on cell surface glycans. Part XVIII. Synthetic studies on nephritogenic glycosides. Synthesis of N-(. BETA.-L-aspartyl)-. ALPHA.-D-glucopyranosylamine. | |
WINTER JR | CARBON-CARBON BOND FORMATION AT C-4'OF A NUCLEOSIDE. SYNTHESIS AND UTILIZATION OF NUCLEOSIDE 4', 5'-ENAMINES. | |
IT8309363A1 (it) | "3" epistreptomicina e suo diidro derivato, e produzione di questi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired |